Effective treatment of hypereosinophilic syndrome with imatinib mesylate
Imatinib mesylate treatment is highly effective in chronic myeloid leukaemia and recent data have suggested that imatinib mesylate is also effective in the treatment of idiopathic hypereosinophilicsyndrome (HES). Six patients with HES were treated daily with 100 mg imatinib mesylate. Five patients h...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , |
| التنسيق: | article |
| منشور في: |
2003
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/11087 https://doi.org/10.1038/sj.thj.6200294 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://www.researchgate.net/profile/Beatrice_Chami/publication/8962207_Effective_treatment_of_hypereosinophilic_syndrome_with_imatinib_mesylate/links/545868ee0cf26d5090ab62a9.pdf |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
الانترنت
http://hdl.handle.net/10725/11087https://doi.org/10.1038/sj.thj.6200294
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.researchgate.net/profile/Beatrice_Chami/publication/8962207_Effective_treatment_of_hypereosinophilic_syndrome_with_imatinib_mesylate/links/545868ee0cf26d5090ab62a9.pdf